Pre-emptive morphine treatment abolishes nerve injury-induced lysophospholipid synthesis in mass spectrometrical analysis

Lysophosphatidic acid as an initiator of neuropathic pain: biosynthesis and demyelination

(2011) Hiroshi Ueda et al.   Clinical Lipidology

LPA Receptors: Subtypes and Biological Actions

(2010) Ji Woong Choi et al.   Annual Review of Pharmacology and Toxicology

Microglial activation mediates de novo lysophosphatidic acid production in a model of neuropathic pain

(2010) Lin Ma et al.   JOURNAL OF NEUROCHEMISTRY

Epigenetic Gene Silencing Underlies C-Fiber Dysfunctions in Neuropathic Pain

(2010) H. Uchida et al.   JOURNAL OF NEUROSCIENCE

Evidence for De Novo Synthesis of Lysophosphatidic Acid in the Spinal Cord through Phospholipase A2 and Autotaxin in Nerve Injury-Induced Neuropathic Pain

(2010) L. Ma et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Analysis of various organic and organometallic compounds using nanostructure-assisted laser desorption/ionization time-of-flight mass spectrometry (NALDI-TOFMS)

(2010) Mark F. Wyatt et al.   JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY

Autotaxin and Lysophosphatidic Acid1 receptor-Mediated Demyelination of Dorsal Root Fibers by Sciatic Nerve Injury and Intrathecal Lysophosphatidylcholine

(2010) Jun Nagai et al.   Molecular Pain

Imaging mass spectrometry revealed the production of lyso-phosphatidylcholine in the injured ischemic rat brain

(2010) S. Koizumi et al.   NEUROSCIENCE

International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid Receptor Nomenclature

(2010) J. Chun et al.   PHARMACOLOGICAL REVIEWS

A clean-up technology for the simultaneous determination of lysophosphatidic acid and sphingosine-1-phosphate by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry using a phosphate-capture molecule, Phos-tag

(2010) Jun-ichi Morishige et al.   RAPID COMMUNICATIONS IN MASS SPECTROMETRY

Autotaxin enzyme immunoassay in human cerebrospinal fluid samples

(2009) Kazuhiro Nakamura et al.   CLINICA CHIMICA ACTA

Evidence for lysophosphatidic acid 1 receptor signaling in the early phase of neuropathic pain mechanisms in experiments using Ki-16425, a lysophosphatidic acid 1 receptor antagonist

(2009) Lin Ma et al.   JOURNAL OF NEUROCHEMISTRY

Lysophosphatidic Acid-3 Receptor-Mediated Feed-Forward Production of Lysophosphatidic Acid: an Initiator of Nerve Injury-Induced Neuropathic Pain

(2009) Lin Ma et al.   Molecular Pain

Lysophosphatidic acid (LPA) receptors: Signaling properties and disease relevance

(2009) Mu-En Lin et al.   PROSTAGLANDINS & OTHER LIPID MEDIATORS

Two pathways for lysophosphatidic acid production

(2008) J AOKI   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Lysophosphatidic acid (LPA) and its receptors

(2008) Kyoko Noguchi et al.   CURRENT OPINION IN PHARMACOLOGY

Simultaneous stimulation of spinal NK1 and NMDA receptors produces LPC which undergoes ATX-mediated conversion to LPA, an initiator of neuropathic pain

(2008) Makoto Inoue et al.   JOURNAL OF NEUROCHEMISTRY

Peripheral Mechanisms of Neuropathic Pain — Involvement of Lysophosphatidic Acid Receptor-Mediated Demyelination

(2008) Hiroshi Ueda   Molecular Pain

Autotaxin, a Synthetic Enzyme of Lysophosphatidic Acid (LPA), Mediates the Induction of Nerve-Injured Neuropathic Pain

(2008) Makoto Inoue et al.   Molecular Pain

Pathological and protective roles of glia in chronic pain

(2008) Erin D. Milligan et al.   NATURE REVIEWS NEUROSCIENCE